Homeostatic T cell proliferation after islet transplantation

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Monti, Paolo ^a   Piemonti, Lorenzo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CYCLOSPORIN A; DACLIZUMAB; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE 65; INOSINATE DEHYDROGENASE; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; TRANSACTIVATOR PROTEIN;

ANTIGEN SPECIFICITY; AUTOIMMUNITY; BIOLOGICAL ACTIVITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIVISION; CELL EXPANSION; CELL SURVIVAL; DNA SYNTHESIS; GLYCATION; HAPLOTYPE; HUMAN; HYPERGLYCEMIA; IMMUNOLOGICAL MEMORY; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY GRAFT; LONG TERM SURVIVAL; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MAINTENANCE THERAPY; MEMORY CELL; MEMORY T LYMPHOCYTE; MONOTHERAPY; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PHENOTYPE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; REVIEW; RNA PROCESSING; SIGNAL TRANSDUCTION; STEADY STATE; T CELL PROLIFERATION; HOMEOSTASIS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; RECURRENT DISEASE; T LYMPHOCYTE SUBPOPULATION; DIABETES MELLITUS, TYPE 1;

AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; HOMEOSTASIS; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSION; INTERLEUKIN-7; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTE ACTIVATION; RECURRENCE; T-LYMPHOCYTE SUBSETS;

EID: 84881530414     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/217934     Document Type: Review

References (66)

1. Ricordi C., Strom T. B., Clinical islet transplantation: advances and immunological challenges. Nature Reviews Immunology 2004 4 4 259 268 2-s2.0-1842731851 (Pubitemid 38478661)
2. Barton F. B., Rickels M. R., Alejandro R., Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 35 7 1436 1445
3. Di Lorenzo T. P., Peakman M., Roep B. O., Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clinical and Experimental Immunology 2007 148 1 1 16 2-s2.0-33847629171 10.1111/j.1365-2249.2006.03244.x (Pubitemid 46364983)
4. Pietropaolo M., Towns R., Eisenbarth G. S., Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes. Cold Spring Harbor Perspectives in Medicine 2012 2 10 10.1101/cshperspect.a012831
5. Piemonti L., Everly M. J., Maffi P., Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes. Diabetes 2013 62 5 1656 1664 10.2337/db12-1258
6. Roep B. O., Stobbe I., Duinkerken G., van Rood J. J., Lernmark Å., Keymeulen B., Pipeleers D., Claas F. H. J., de Vries R. R. P., Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes 1999 48 3 484 490 2-s2.0-0032971910 (Pubitemid 29106860)
7. Datta S., Sarvetnick N., Lymphocyte proliferation in immune-mediated diseases. Trends in Immunology 2009 30 9 430 438 2-s2.0-68949166331 10.1016/j.it.2009.06.002
8. Monti P., Heninger A., Bonifacio E., Differentiation, expansion, and homeostasis of autoreactive T cells in type 1 diabetes mellitus. Current Diabetes Reports 2009 9 2 113 118 2-s2.0-63349109137 10.1007/s11892-009-0020-y
9. Viglietta V., Kent S. C., Orban T., Hafler D. A., GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. The Journal of Clinical Investigation 2002 109 7 895 903 2-s2.0-0036212794 10.1172/JCI200214114 (Pubitemid 34275110)
10. + T cells in healthy and type 1 diabetic subjects. Journal of Autoimmunity 2005 25 4 303 311 2-s2.0-27844518834 10.1016/j.jaut.2005.08.007 (Pubitemid 41642977)
11. Monti P., Scirpoli M., Rigamonti A., Mayr A., Jaeger A., Bonfanti R., Chiumello G., Ziegler A. G., Bonifacio E., Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes. The Journal of Immunology 2007 179 9 5785 5792 2-s2.0-38449111219
12. Sibley R. K., Sutherland D. E. R., Goetz F., Michael A. F., Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Laboratory Investigation 1985 53 2 132 144 2-s2.0-0021873134 (Pubitemid 15049005)
13. Sutherland D. E., Sibley R., Xu X. Z., Michael A., Srikanta A. M., Taub F., Najarian J., Goetz F. C., Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes. Transactions of the Association of American Physicians 1984 97 80 87 2-s2.0-0021697880
14. Braghi S., Bonifacio E., Secchi A., Di Carlo V., Pozza G., Bosi E., Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes 2000 49 2 218 224 2-s2.0-0033958643 (Pubitemid 30071000)
15. Bosi E., Braghi S., Maffi P., Scirpoli M., Bertuzzi F., Pozza G., Secchi A., Bonifacio E., Autoantibody response to islet transplantation in type 1 diabetes. Diabetes 2001 50 7-12 2464 2471 2-s2.0-0035515764 (Pubitemid 33642763)
16. + T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers. Diabetes 2010 59 7 1721 1730 2-s2.0-77951983004 10.2337/db09-1486
17. Vendrame F., Pileggi A., Laughlin E., Allende G., Martin-Pagola A., Molano R. D., Diamantopoulos S., Standifer N., Geubtner K., Falk B. A., Ichii H., Takahashi H., Snowhite I., Chen Z., Mendez A., Chen L., Sageshima J., Ruiz P., Ciancio G., Ricordi C., Reijonen H., Nepom G. T., Burke G. W. III, Pugliese A., Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 2010 59 4 947 957 2-s2.0-77951168859 10.2337/db09-0498
18. Occhipinti M., Lampasona V., Vistoli F., Bazzigaluppi E., Scavini M., Boggi U., Marchetti P., Bosi E., Zinc transporter 8 autoantibodies increase the predictive value of islet autoantibodies for function loss of technically successful solitary pancreas transplant. Transplantation 2011 92 6 674 677 2-s2.0-80052675542 10.1097/TP.0b013e31822ae65f
19. van de Linde P., Vd Boog P. J. M., Tysma O. M. H., Elliott J. F., Roelen D. L., Claas F. H. J., de Fijter J. W., Roep B. O., Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin. Clinical and Experimental Immunology 2007 149 1 56 62 2-s2.0-34250160238 10.1111/j.1365-2249.2007.03400.x (Pubitemid 46897110)
20. + T cells in autoimmune diabetes after pancreas transplantation. Clinical Immunology 2008 128 1 23 30 2-s2.0-49949152047 10.1016/j.clim.2008.03.459
21. Vrisekoop N., den Braber I., de Boer A. B., Ruiter A. F. C., Ackermans M. T., van der Crabben S. N., Schrijver E. H. R., Spierenburg G., Sauerwein H. P., Hazenberg M. D., de Boer R. J., Miedema F., Borghans J. A. M., Tesselaar K., Sparse production but preferential incorporation of recently produced naïve T cells in the human peripheral pool. Proceedings of the National Academy of Sciences of the United States of America 2008 105 16 6115 6120 2-s2.0-43149105163 10.1073/pnas.0709713105 (Pubitemid 351758408)
22. + T cells in healthy humans. The Journal of Experimental Medicine 2004 200 2 255 260 2-s2.0-3242751959 10.1084/jem.20040341 (Pubitemid 38982184)
23. Takada K., Jameson S. C., Naive T cell homeostasis: from awareness of space to a sense of place. Nature Reviews Immunology 2009 9 12 823 832 2-s2.0-72949100401 10.1038/nri2657
24. Boyman O., Létourneau S., Krieg C., Sprent J., Homeostatic proliferation and survival of naïve and memory T cells. European Journal of Immunology 2009 39 8 2088 2094 2-s2.0-70249143637 10.1002/eji.200939444
25. Swain S. L., Hu H., Huston G., Class II-independent generation of CD4 memory T cells from effectors. Science 1999 286 5443 1381 1383 2-s2.0-0032589687 10.1126/science.286.5443.1381 (Pubitemid 29535902)
26. Murali-Krishna K., Lau L. L., Sambhara S., Lemonnier F., Altman J., Ahmed R., Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 1999 286 5443 1377 1381 2-s2.0-0032720640 10.1126/science.286.5443.1377 (Pubitemid 29535901)
27. Tchao N. K., Turka L. A., Lymphodepletion and homeostatic proliferation: implications for transplantation. American Journal of Transplantation 2012 12 5 1079 1090 2-s2.0-84860493998 10.1111/j.1600-6143.2012.04008.x
28. + memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 2003 101 11 4260 4266 2-s2.0-0038375013 10.1182/blood-2002-11-3577 (Pubitemid 36857786)
29. Rieben R., Seebach J. D., Xenograft rejection: IgG1, complement and NK cells team up to activate and destroy the endothelium. Trends in Immunology 2005 26 1 2 5 2-s2.0-11144245342 10.1016/j.it.2004.11.011 (Pubitemid 40051983)
30. King C., Ilic A., Koelsch K., Sarvetnick N., Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004 117 2 265 277 2-s2.0-1942453326 10.1016/S0092-8674(04)00335-6 (Pubitemid 38496245)
31. Penaranda C., Kuswanto W., Hofmann J., Kenefeck R., Narendran P., Walker L. S. K., IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells. Proceedings of the National Academy of Sciences of the United States of America 2012 109 31 12668 12673 10.1073/pnas.1203692109
32. Lee L., Logronio K., Huan G., Anti-IL-7 receptor- α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function. Proceedings of the National Academy of Sciences of the United States of America 2012 109 31 12674 12679 10.1073/pnas.1203795109
33. Molano R. D., Pileggi A., Berney T., Poggioli R., Zahr E., Oliver R., Ricordi C., Rothstein D. M., Basadonna G. P., Inverardi L., Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154. Diabetes 2003 52 4 957 964 2-s2.0-0037381446 10.2337/diabetes.52.4.957 (Pubitemid 36384266)
34. Molano R. D., Pileggi A., Berney T., Poggioli R., Zahr E., Oliver R., Malek T. R., Ricordi C., Inverardi L., Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. Transplantation 2003 75 11 1812 1819 2-s2.0-0037708577 10.1097/01.TP.0000064622.54799.0E (Pubitemid 36734636)
35. Harsunen M. H., Puff R., D'Orlando O., Reduced blood leukocyte and neutrophil numbers in the pathogenesis of type 1 diabetes. Hormone and Metabolic Research 2013 45 6 467 470 10.1055/s-0032-1331226
36. Todd J. A., Walker N. M., Cooper J. D., Smyth D. J., Downes K., Plagnol V., Bailey R., Nejentsev S., Field S. F., Payne F., Lowe C. E., Szeszko J. S., Hafler J. P., Zeitels L., Yang J. H. M., Vella A., Nutland S., Stevens H. E., Schuilenburg H., Coleman G., Maisuria M., Meadows W., Smink L. J., Healy B., Burren O. S., Lam A. A. C., Ovington N. R., Allen J., Adlem E., Leung H.-T., Wallace C., Howson J. M. M., Guja C., Ionescu-Tîrgovişte C., Simmonds M. J., Heward J. M., Gough S. C. L., Dunger D. B., Wicker L. S., Clayton D. G., Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nature Genetics 2007 39 7 857 864 2-s2.0-34347341846 10.1038/ng2068 (Pubitemid 47018195)
37. Monti P., Brigatti C., Krasmann M., Ziegler A. G., Bonifacio E., Concentration and activity of the soluble form of the interleukin-7 receptor alpha identifies an interplay between hyperglycemia and immune function. Diabetes 2013 62 2500 2508 10.2337/db12-1726
38. Monti P., Scirpoli M., Maffi P., Ghidoli N., de Taddeo F., Bertuzzi F., Piemonti L., Falcone M., Secchi A., Bonifacio E., Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. The Journal of Clinical Investigation 2008 118 5 1806 1814 2-s2.0-43049130746 10.1172/JCI35197 (Pubitemid 351632383)
39. Gurkan S., Luan Y., Dhillon N., Allam S. R., Montague T., Bromberg J. S., Ames S., Lerner S., Ebcioglu Z., Nair V., Dinavahi R., Sehgal V., Heeger P., Schroppel B., Murphy B., Immune reconstitution following rabbit antithymocyte globulin. American Journal of Transplantation 2010 10 9 2132 2141 2-s2.0-77956168784 10.1111/j.1600-6143.2010.03210.x
40. + T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression. American Journal of Transplantation 2008 8 2 338 347 2-s2.0-38149086827 10.1111/j.1600-6143.2007.02078.x
41. Pearl J. P., Parris J., Hale D. A., Hoffmann S. C., Bernstein W. B., McCoy K. L., Swanson S. J., Mannon R. B., Roederer M., Kirk A. D., Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. American Journal of Transplantation 2005 5 3 465 474 2-s2.0-20044380331 10.1111/j.1600-6143.2005. 00759.x (Pubitemid 40313337)
42. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., Solomon M., Selby W., Alexander S. I., Nanan R., Kelleher A., de St. Groth B. F., Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. The Journal of Experimental Medicine 2006 203 7 1693 1700 2-s2.0-33745813929 10.1084/jem.20060468 (Pubitemid 44036275)
43. + T reg cells. The Journal of Experimental Medicine 2006 203 7 1701 1711 2-s2.0-33745817085 10.1084/jem.20060772 (Pubitemid 44036276)
44. + regulatory T cells and allows expansion of alloreactive and autoreactive T cells. The Journal of Immunology 2012 189 12 5649 5658 10.4049/jimmunol.1201286
45. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. The Journal of Experimental Medicine 2001 193 11 1295 1302 2-s2.0-0035806323 10.1084/jem.193.11.1295 (Pubitemid 32524779)
46. Kaminitz A., Mizrahi K., Yaniv I., Stein J., Askenasy N., Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells. Journal of Autoimmunity 2010 35 2 145 152 2-s2.0-77955924797 10.1016/j.jaut.2010.06.002
47. + T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation. Haematologica 2008 93 3 423 430 2-s2.0-40849141379 10.3324/haematol.11897 (Pubitemid 351398644)
48. + lymphopenia following allogeneic hematopoietic stem cell transplantation. The Journal of Clinical Investigation 2010 120 5 1479 1493 2-s2.0-77951870520 10.1172/JCI41072
49. Toso C., Edgar R., Pawlick R., Emamaullee J., Merani S., Dinyari P., Mueller T. F., Shapiro A. M. J., Anderson C. C., Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation. Transplant International 2009 22 2 182 191 2-s2.0-58149310848 10.1111/j.1432-2277.2008.00746.x
50. Cancro M. P., The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity. Annals of the Rheumatic Diseases 2006 65 supplement 3 III34 III36 2-s2.0-33750341510 10.1136/ard.2006.058412 (Pubitemid 44629099)
51. Miller J. P., Stadanlick J. E., Cancro M. P., Space, selection, and surveillance: setting boundaries with BLyS. The Journal of Immunology 2006 176 11 6405 6410 2-s2.0-33646891951 (Pubitemid 43787821)
52. Thien M., Phan T. G., Gardam S., Amesbury M., Basten A., MacKay F., Brink R., Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 2004 20 6 785 798 2-s2.0-2942518502 10.1016/j.immuni.2004.05.010 (Pubitemid 38757447)
53. Anolik J. H., Friedberg J. W., Zheng B., Barnard J., Owen T., Cushing E., Kelly J., Milner E. C. B., Fisher R. I., Sanz I., B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny. Clinical Immunology 2007 122 2 139 145 2-s2.0-33846104336 10.1016/j.clim.2006.08.009 (Pubitemid 46073890)
54. Anolik J. H., Barnard J., Owen T., Zheng B., Kemshetti S., Looney R. J., Sanz I., Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthritis & Rheumatism 2007 56 9 3044 3056 2-s2.0-34848912304 10.1002/art.22810 (Pubitemid 47502752)
55. Liu C., Noorchashm H., Sutter J. A., Naji M., Prak E. L., Boyer J., Green T., Rickels M. R., Tomaszewski J. E., Koeberlein B., Wang Z., Paessler M. E., Velidedeoglu E., Rostami S. Y., Yu M., Barker C. F., Naji A., B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nature Medicine 2007 13 11 1295 1298 2-s2.0-35948935946 10.1038/nm1673 (Pubitemid 350073600)
56. p a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. The Journal of Biological Chemistry 1993 268 5 3747 3752 2-s2.0-0027339327 (Pubitemid 23071024)
57. Brown E. J., Albers M. W., Shin T. B., Ichikawa K., Keith C. T., Lane W. S., Schreiber S. L., A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 1994 369 6483 756 758 2-s2.0-0028360374 10.1038/369756a0 (Pubitemid 24225367)
58. Mazzucchelli R., Durum S. K., Interleukin-7 receptor expression: intelligent design. Nature Reviews Immunology 2007 7 2 144 154 2-s2.0-33846632842 10.1038/nri2023 (Pubitemid 46178275)
59. Pallard C., Stegmann A. P. A., van Kleffens T., Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors. Immunity 1999 10 5 525 535 2-s2.0-0033136288 10.1016/S1074-7613(00)80052-7 (Pubitemid 29262655)
60. Queen C., Schneider W. P., Selick H. E., Payne P. W., Landolfi N. F., Duncan J. F., Avdalovic N. M., Levitt M., Junghans R. P., Waldmann T. A., A humanized antibody that binds to the interleukin 2 receptor. Proceedings of the National Academy of Sciences of the United States of America 1989 86 24 10029 10033 2-s2.0-0024815233 10.1073/pnas.86.24.10029 (Pubitemid 20030769)
61. + T cells. American Journal of Transplantation 2009 9 12 2727 2735 2-s2.0-72449208029 10.1111/j.1600-6143. 2009.02825.x
62. Kitchin J. E. S., Pomeranz M. K., Pak G., Washenik K., Shupack J. L., Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses. Journal of the American Academy of Dermatology 1997 37 3 445 449 2-s2.0-0030928540 10.1016/S0190-9622(97)70147-6 (Pubitemid 27430644)
63. Goodwin R. G., Friend D., Ziegler S. F., Jerzy R., Falk B. A., Gimpel S., Cosman D., Dower S. K., March C. J., Namen A. E., Park L. S., Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell 1990 60 6 941 951 2-s2.0-0025350049 10.1016/0092-8674(90)90342-C (Pubitemid 20103876)
64. McKay F. C., Swain L. I., Schibeci S. D., Rubio J. P., Kilpatrick T. J., Heard R. N., Stewart G. J., Booth D. R., Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis. Genes and Immunity 2008 9 1 1 6 2-s2.0-38549180589 10.1038/sj.gene.6364436 (Pubitemid 351150028)
65. Hoe E., McKay F. C., Schibeci S. D., Gandhi K., Heard R. N., Stewart G. J., Booth D. R., Functionally significant differences in expression of disease-associated IL-7 receptor α haplotypes in CD4 T cells and dendritic cells. The Journal of Immunology 2010 184 5 2512 2517 2-s2.0-77951910573 10.4049/jimmunol.0902900
66. Faller E. M., Sugden S. M., McVey M. J., Kakal J. A., MacPherson P. A., Soluble HIV Tat protein removes the IL-7 receptor α -chain from the surface of resting CD8 T cells and targets it for degradation. The Journal of Immunology 2010 185 5 2854 2866 2-s2.0-78049385847 10.4049/jimmunol.0902207